Changes

no edit summary
Line 368: Line 368:  
|Acute myeloid leukaemia with CEBPA mutation
 
|Acute myeloid leukaemia with CEBPA mutation
 
|Disease
 
|Disease
|Paul Defazio, MSc, Monash Health
+
|
 
|
 
|
 
|
 
|
Line 376: Line 376:  
|
 
|
 
|
 
|
|
+
|Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA
|
+
|Paul Defazio, MSc, Monash Health
|
+
|Complete
 
|
 
|
 
|
 
|
Line 384: Line 384:  
|Acute myeloid leukaemia, myelodysplasia-related
 
|Acute myeloid leukaemia, myelodysplasia-related
 
|Disease
 
|Disease
|Fei Yang, MD, FACMG  <br> Oregon Health & Science University, Portland, OR
+
|
 
|
 
|
 
|
 
|
Line 392: Line 392:  
|
 
|
 
|
 
|
|
+
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes
|
+
|Fei Yang, MD, FACMG  <br> Oregon Health & Science University
|
+
|Complete
 
|
 
|
 
|
 
|
Line 408: Line 408:  
|
 
|
 
|
 
|
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
 
|-
 
|-
 
|Acute myeloid leukaemia with minimal differentiation
 
|Acute myeloid leukaemia with minimal differentiation
Line 424: Line 424:  
|
 
|
 
|
 
|
|
+
|Acute Myeloid Leukemia (AML) with Minimal Differentiation
|
+
|Celeste Eno, PhD, Cedars Sinai Medical Center, Los Angeles,  Fabiola Quintero-Rivera, MD, FACMG, University of California Irvine
|
+
|Complete
 
|
 
|
 
|
 
|
Line 440: Line 440:  
|
 
|
 
|
 
|
|
+
|Acute Myeloid Leukemia (AML) without Maturation
|
+
|Jennelle C. Hodge, PhD, FACMG
|
+
|Complete
 
|
 
|
 
|
 
|
Line 456: Line 456:  
|
 
|
 
|
 
|
|
+
|Acute Myeloid Leukemia (AML) with Maturation
|
+
|Jennelle C. Hodge, PhD, FACMG
|
+
|Complete
 
|
 
|
 
|
 
|